John C. Jacobs
CIK: 0001820836
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NOVAVAX INC
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Mar 3, 2026NVAX
NOVAVAX INC
Exercise(M)Direct150.2K shares- - Mar 3, 2026NVAX
NOVAVAX INC
Tax Payment(F)Direct69.3K shares at avg. $9.49$658K - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectNon-Statutory Stock Option NQ
551.5K shares- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectNon-Statutory Stock Option NQ
551.5K shares at avg. $9.09- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectRestricted Stock Units
367.5K shares- - Mar 1, 2026NVAX
NOVAVAX INC
Exercise(M)Direct83.3K shares- - Mar 1, 2026NVAX
NOVAVAX INC
Tax Payment(F)Direct38.5K shares at avg. $10.14$390K - Jan 23, 2026NVAX
NOVAVAX INC
Tax Payment(F)Direct39.1K shares at avg. $9.17$359K - Jan 23, 2026NVAX
NOVAVAX INC
Exercise(M)Direct83.2K shares- - Mar 3, 2025NVAX
NOVAVAX INC
Award(A)Direct2025 Restricted Stock Units RSU
450.5K shares- - Mar 3, 2025NVAX
NOVAVAX INC
Award(A)Direct2025 Non-statutory Stock Option NQ
676K shares at avg. $7.87- - Mar 1, 2025NVAX
NOVAVAX INC
Tax Payment(F)Direct38.5K shares at avg. $8.33$320K - Mar 1, 2025NVAX
NOVAVAX INC
Exercise(M)Direct83.3K shares- - Jan 23, 2025NVAX
NOVAVAX INC
Tax Payment(F)Direct38.9K shares at avg. $9.55$371K - Jan 23, 2025NVAX
NOVAVAX INC
Exercise(M)Direct83.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVAX NOVAVAX INC | Exercise(M) | 150,167 | - | $0 | Direct |
| Mar 3, 2026 | NVAX NOVAVAX INC | Tax Payment(F) | 69,288 | $9.49 | $657,543 | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Non-Statutory Stock Option NQ | 551,500 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Non-Statutory Stock Option NQ | 551,500 | $9.09 | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Restricted Stock Units | 367,500 | - | - | Direct |
| Mar 1, 2026 | NVAX NOVAVAX INC | Exercise(M) | 83,333 | - | $0 | Direct |
| Mar 1, 2026 | NVAX NOVAVAX INC | Tax Payment(F) | 38,450 | $10.14 | $389,883 | Direct |
| Jan 23, 2026 | NVAX NOVAVAX INC | Tax Payment(F) | 39,132 | $9.17 | $358,840 | Direct |
| Jan 23, 2026 | NVAX NOVAVAX INC | Exercise(M) | 83,197 | - | $0 | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award(A) 2025 Restricted Stock Units RSU | 450,500 | - | - | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award(A) 2025 Non-statutory Stock Option NQ | 676,000 | $7.87 | - | Direct |
| Mar 1, 2025 | NVAX NOVAVAX INC | Tax Payment(F) | 38,451 | $8.33 | $320,297 | Direct |
| Mar 1, 2025 | NVAX NOVAVAX INC | Exercise(M) | 83,334 | - | - | Direct |
| Jan 23, 2025 | NVAX NOVAVAX INC | Tax Payment(F) | 38,873 | $9.55 | $371,237 | Direct |
| Jan 23, 2025 | NVAX NOVAVAX INC | Exercise(M) | 83,196 | - | $0 | Direct |
1-15 of 15 transactions
About Jacobs John C
Jacobs John C (SEC CIK 0001820836) files insider reports with the SEC as President and CEO of NOVAVAX INC (NVAX).
Signal8 holds 7 ownership filings by Jacobs John C, all Form 4s, filed between Jan 27, 2025 and Mar 9, 2026. Those filings report 15 transactions, from Jan 23, 2025 to Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jacobs John C's filings is in GAITHERSBURG, MD.
Recent filings by Jacobs John C
- Mar 3, 2026: Option exercise of NVAX shares (Form 4, code M).
- Mar 3, 2026: Tax withholding of NVAX shares (Form 4, code F).
- Mar 2, 2026: Grants or awards of NVAX derivative securities (3 lines, Form 4, code A).
- Mar 1, 2026: Option exercise of NVAX shares (Form 4, code M).
- Mar 1, 2026: Tax withholding of NVAX shares (Form 4, code F).
Other insiders filing for NOVAVAX INC (NVAX)
- Rodgers Richard J, Director
- King Rachel K., Director
- DOUGLAS RICHARD, Director
- MCGLYNN MARGARET G, Director
- MOTT DAVID M, Director
- Alton Gregg H, Director